Your session is about to expire
← Back to Search
Ferric Carboxymaltose for Iron-Deficiency Anemia
Study Summary
This trial will test whether iron supplementation can improve exercise ability in heart failure patients.
- Iron-Deficiency Anemia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the uppermost limit of participants enrolled in this clinical research?
"Indeed, the information found on clinicaltrials.gov implies that this research is still open for enrollment. It was posted on September 7th 2017 and last updated on February 2nd 2022 with a requirement of 32 participants from 1 site."
Does this research encompass participants aged 30 and over?
"The present clinical study is only open to patients between 21 and 75 years of age. There are 45 trials accommodating those under 18, while 733 studies focus on individuals over the age of 65."
What population is eligible to participate in this experiment?
"This medical study has the capacity to enrol 32 individuals between 21-75 suffering from heart failure. Furthermore, they must meet certain criteria such as a left ventricular ejection fraction below 40%, NYHA Class II-III symptoms persisting for at least 3 months and functional iron deficiency (defined as serum ferritin level <100 ng/ml or between 100 and 299 ng/ml with transferrin saturation <20%). Additionally, they also need to be willing to provide written informed consent."
Have other clinical trials employed Ferric Carboxymaltose in the past?
"Currently, 21 clinical trials are in progress that analyze the efficacy of Ferric Carboxymaltose. Of those studies, 6 have reached Phase 3 and they span 398 medical sites all over Kano and Lagos."
Is enrollment for this clinical trial still available?
"Affirmative. The records on clinicaltrials.gov reveal that this experiment is in the process of recruiting patients, with 32 subjects needed to be enrolled from 1 site. It was first published on September 7th 2017 and most recently updated on February 2nd 2022."
How hazardous is Ferric Carboxymaltose to individuals?
"Ferric Carboxymaltose has been evaluated in Phase 2 trials, providing the team at Power with enough data to give it a safety score of two. Unfortunately, there is not yet any evidence for its efficacy."
What medical ailments is Ferric Carboxymaltose utilized to combat?
"Ferric Carboxymaltose is routinely employed to address iron deficiency, and it has also been known to successfully treat conditions such as oral cavity problems, anemia due to breast feeding."
Share this study with friends
Copy Link
Messenger